Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature

Michael Gnant1, Philippe Clézardin

  • 1Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. michael.gnant@meduniwien.ac.at

Cancer Treatment Reviews
|October 11, 2011
PubMed

Insights

Bisphosphonates, used to treat bone disease, show promise in preventing cancer recurrence by altering the bone marrow microenvironment. These agents exhibit direct and indirect anticancer effects, impacting both tumor cells and their surroundings.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • The bone marrow microenvironment facilitates cancer cell evasion of therapy, contributing to disease persistence and relapse.
  • Dormant micrometastases are implicated in cancer recurrence, but the distinction between cancer stem cells and those with limited metastatic potential remains unclear.
  • Bisphosphonates are established treatments for malignant bone disease and bone loss associated with cancer therapy.

Purpose of the Study:

  • To review preclinical and clinical studies on bisphosphonates' anticancer activities.
  • To explore how bisphosphonates modify the bone marrow microenvironment to inhibit cancer cell survival.
  • To summarize the direct and indirect anticancer effects of bisphosphonates on tumor cells and their microenvironment.

Main Methods:

  • Literature review of preclinical and early clinical studies.
  • Analysis of bisphosphonate mechanisms of action.
  • Examination of clinical outcomes in various cancer types.

Main Results:

  • Bisphosphonates demonstrate direct and indirect anticancer activities.
  • Zoledronic acid improved survival in adjuvant breast cancer, multiple myeloma, and other advanced cancers.
  • Antiresorptive therapy delayed bone metastases in prostate cancer.

Conclusions:

  • Altering the bone marrow microenvironment is a key strategy to prevent cancer recurrence.
  • Bisphosphonates offer potential anticancer benefits by targeting both tumor cells and their microenvironment.
  • Further research is ongoing to elucidate the full anticancer potential of bisphosphonates and related agents.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...